Alzheimer's disease center seeks patients for new drug studies

DALLAS, Texas, August 29, 1996 -- Two major drug trials recently initiated at UT Southwestern Medical Center at Dallas may offer hope for the millions of Americans affected by Alzheimer's disease.

UT Southwestern is one of 30 medical centers across the nation -- and the only one in North Texas -- testing propentofylline, an oral drug for Alzheimer's that also may be effective for patients who experience dementia as a result of strokes. If the medication proves effective, it could improve the condition of patients or at least slow the progression of Alzheimer's symptoms, said psychiatry research nurse administrator Doris Svetlik. The most common symptoms of the disease are memory loss, confusion, difficulty in finding the correct words for articulate conversation, difficulty recalling names and repetition of previous conversation.

Researchers at UT Southwestern are hoping to enroll about 15 patients and have set a maximum of 24 patients for the study. The 48-week trial is open to men and women between the ages of 40 and 90. They also must have a relative or friend who can take them to regular appointments and respond to researchers' inquiries.

Another major drug study involves SB202026, which is being tested at 35 sites around the United States. UT Southwestern again is the only North Texas testing center. Researchers expect to enroll about 15 patients in the 24-week trial. The oral medication is intended to alleviate the major symptoms of Alzheimer's. The participants, like those in the propentofylline trial, must be coherent enough to answer researchers' questions.

"We are encouraged by the number of new medications being developed for Alzheimer's," said Dr. Myron Weiner, vice chairman for clinical services in psychiatry, assistant professor of neurology, holder of the Aradine S. Ard Chair in Brain Science and director of the clinical core of the National Institutes of Health-funded Alzheimer's Disease Center. "We are hopeful that these new drugs

Contact: Emily Martinez
UT Southwestern Medical Center

Page: 1 2

Related medicine news :

1. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
2. Neuronal death and processing of Tau protein in Alzheimers disease
3. Researchers discover link between insulin and Alzheimers
4. New trials for counseling caregivers and patients with Alzheimers begin
5. Marijuana ingredient may stall decline from Alzheimers
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
8. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
9. Nanoscale diagnostic sets sights on Alzheimers
10. New test is first step in early detection of Alzheimers disease
11. Older people with the Alzheimers gene find it harder to remember to remember even if healthy

Post Your Comments:

(Date:8/14/2019)... PLEASANT HILL, Calif. (PRWEB) , ... August 13, 2019 , ... ... has welcomed Maria P. Falaschi, vice president of operations and information technology, and Elie ... growing executive team as part of New U Life’s commitment to expanding its corporate ...
(Date:8/14/2019)... ... August 14, 2019 , ... Today, consumers are taking a harder ... impacts their physical body, emotions and energy levels. The trick is finding food and ... , That’s why founder Chris Harper created Chase – a delicious, ...
(Date:8/12/2019)... ... August 12, 2019 , ... Cryotherapy has recently been the target ... Oakland Raiders. However, the cause of Brown’s injury was not due to cryotherapy, but ... session. Numerous NFL teams, such as the Dallas Cowboys, the Washington Redskins, the Denver ...
(Date:8/12/2019)... ... August 12, 2019 , ... Ziegler, a specialty investment ... Bonds for Lesley University, which is currently rated A-/Stable through S&P. Issued through ... used primarily to refund the outstanding debt on the Series 2011 bonds, the ...
(Date:8/12/2019)... ... August 12, 2019 , ... Israeli medical ... significant therapeutic benefits in the use of floristry as treatment for fibromyalgia. ... a total of 61 female fibromyalgia patients participating in a 12-week floral design ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... OCT Clinical Trials ... has successfully completed enrollment of 690 patients for a phase III efficacy study ... randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of MED2002, which is ...
(Date:8/15/2019)... SAN RAFAEL, Calif. (PRWEB) , ... August 15, ... ... company, has launched a Private Client service for intended parents who are looking ... is for those fertility patients who are looking for the ultimate concierge service ...
(Date:8/14/2019)... ... August 14, 2019 , ... Canyon ... of 5,217 sf. With pet care at the forefront of design, the project ... endoscopy and CT. Twelve exam rooms, office space and a dedicated grieving space ...
Breaking Medicine Technology:
Cached News: